Long-term anticonvulsant therapy leads to low bone mineral density - evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells
J. Feldkamp et al., Long-term anticonvulsant therapy leads to low bone mineral density - evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells, EXP CL E D, 108(1), 2000, pp. 37-43
Citations number
38
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
Anticonvulsant therapy causes changes in calcium and bone metabolism and ma
y lead to decreased bone mass with the risk of osteoporotic fractures. The
two widely used antiepileptic drugs phenytoin and carbamazepine are recogni
zed to have direct effects on bone cells. The aim of our study was to measu
re the influence of long-term treatment with antiepileptic drugs on bone mi
neral density (BMD) and to look on direct effects of carbamazepine and phen
ytoin on human osteoblast-like cells.
BMD was measured by dual-energy X-ray absorptiometry. Markers of bone forma
tion and bone resorption were determined in serum and urine. Data of 59 pat
ients were compared to 55 age and sex matched controls. Direct effects of p
henytoin and carbamazepine on human osteoblast-like cells were investigated
in experimental studies.
BMD in the lumbar spine region (L2 through L4) was significantly lower in t
he patient group as compared to controls (p < 0.0004). At femoral sites BMD
was lower in patients, but this difference did not reach statistical signi
ficance. The decrease in BMD at both sites was dependent on the duration of
therapy. Excretion of pyridinoline crosslinks was markedly increased in th
e patients. 25-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 were signif
icantly decreased in patients. Proliferation rate of human osteoblast-like
cells was increased by phenytoin in low doses. Both, phenytoin and carbamaz
epine inhibited cell growth at concentrations equivalent to therapeutic dos
es for the treatment of epileptic diseases.
Our clinical and experimental data indicate that long-term treatment with a
nticonvulsant drugs leads to a lower BMD. The experimentally observed decre
ase in bone cell proliferation might be clinically associated with impaired
new bone formation. Beside alterations in calcium and vitamin D homeostasi
s leading to osteomalazia, direct effects of anticonvulsant drugs on bone c
ells may contribute to the damaging effects on the skeletal system.